Romania loses approximately EUR 18.6 bln, equivalent to 15 pc of its GDP in 2010, because of precarious health conditions, and if the health state of the population improved to the average level of the EU, Romania would have an economic surplus of EUR 6.7 bln, according to a report named ‘The pharmaceutical industry in Romania: main trends and the impact on society and economy,’ issued by the Economic Forecast Institute of the Romanian Academy, with support from the Romanian branch of the Pharmaceutical Research and Manufacturers of America (PhRMA) – Local American Working Group.The report also mentions the fact that the Government had an income exceeding 20 pc of the total value of the prescription-based medicines market, respectively about RON 1.7 bln in 2010, from taxes and dues paid by the pharmaceutical industry to the central budget and to local budgets.
previous post
